philemon trial: ibrutinib, lenalidomide and rituximab in r/r mcl
Published 3 years ago • 79 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
5:12
phase ii trial of acalabrutinib, lenalidomide and rituximab in patients with mcl
-
3:26
phase ii study of acalabrutinib, lenalidomide & rituximab for high tumor burden follicular lymphoma
-
0:18
echemi weekly quality inquiry products—hydrogenated cardanol
-
1:01
10 mini facts about pleomorphic adenoma. last minute revision series for oral pathology
-
0:08
immunolabelling of the golgi and autophagosomes
-
0:19
echemi weekly quality inquiry products—sodium hydroxide #science #innovation#chemical
-
1:44
triangle: ibrutinib with soc or as a substitute to autologous transplantation in first-line mcl
-
2:23
zilo-301: phase iii study of zilovertamab ibrutinib vs ibrutinib in r/r mcl
-
1:35
long-term ibrutinib outcomes vs. prior regimens: pooled analysis in r/r mcl
-
1:11
ibrutinib combined with tgr-1202 in cll and mantle cell lymphoma (mcl): preliminary results
-
4:20
stories of transformation - marianne
-
3:40
treating advanced follicular lymphoma progressive or relapsed after r2
-
20:44
bernard maillère: epitope mapping of therapeutic abs in healthy donors to predict immunogenicity
-
1:23
r2 in the second-line: lenalidomide-rituximab improves pfs in relapsed/refractory nhl
-
3:00
five-year follow-up of the captivate trial: ibrutinib retreatment in patients with cll
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
4:43
how to manage relapsed/refractory mcl - new agents and unmet needs
-
1:31
side-effects of ibrutinib in relapsed/refractory mantle cell lymphoma
-
4:01
ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
-
2:14
single agent ibrutinib produces long-term disease control in waldenström’s: the pivotal trial
-
2:31
long-term follow up of study of obinutuzumab, polatuzumab vedotin, and lenalidomide in r/r fl
-
6:05
real-world data on the effect of ibrutinib flexible dosing treatment strategies on ttnt in cll/sll